Similar articles

• [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].

  Meco G, Casacchia M, Zamponi A, Agnoli A. Meco G, et al. Acta Neurol (Napoli). 1976 Jul-Aug;31(4):479-48. Acta Neurol (Napoli). 1976. PMID: 1037427 Italian. No abstract available.
• Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.

  Parkes JD, Debono AG, Marsden CD. Parkes JD, et al. J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1101-8. doi: 10.1136/jnnp.39.11.1101. J Neurol Neurosurg Psychiatry. 1976. PMID: 1036999 Free PMC article.
• Comparison between lergotrile and bromocriptine in parkinsonism.

  Teychenne PF, Pfeiffer RF, Bern SM, McInturff D, Calne DB. Teychenne PF, et al. Ann Neurol. 1978 Apr;3(4):319-24. doi: 10.1002/ana.410030408. Ann Neurol. 1978. PMID: 666273
• Long-term use of dopamine agonists in Parkinson's disease.

  Jankovic J. Jankovic J. Clin Neuropharmacol. 1985;8(2):131-40. doi: 10.1097/00002826-198506000-00002. Clin Neuropharmacol. 1985. PMID: 3891082 Review. No abstract available.
• Sinemet and the treatment of Parkinsonism.

  Boshes B. Boshes B. Ann Intern Med. 1981 Mar;94(3):364-70. doi: 10.7326/0003-4819-94-3-364. Ann Intern Med. 1981. PMID: 7013595 Review.